Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis

Cardiology Journal

Volumn 18, Issue 5, 2011, Pages 503-514

  Kong, Melissa H ^a   Al Khatib, Sana M ^a   Sanders, Gillian D ^a   Hasselblad, Vic ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Defibrillation; Sudden death

Indexed keywords

PLACEBO;

AGE DISTRIBUTION; AGING; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; META ANALYSIS; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SECONDARY PREVENTION; SUDDEN DEATH; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; TACHYCARDIA;

AGE FACTORS; AGED; AGING; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EVIDENCE-BASED MEDICINE; HOSPITAL MORTALITY; HUMANS; PRIMARY PREVENTION; PROSTHESIS DESIGN; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80053012858     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2011.0005     Document Type: Review

References (48)

1. Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease. Clin Geriatr Med, 2007; 23: 205-219.
2. Al-Khatib SM, Sanders GD, Mark DB et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004. Am Heart J, 2005; 149: 1020-1034.
3. Hohnloser SH, Kuck KH, Dorian P et al.; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med, 2004; 351: 2481-2488.
4. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary- artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med, 1997; 337: 1569-1575.
5. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med, 1996; 335: 1933-1940.
6. Moss AJ, Zareba W, Hall WJ et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883.
7. Buxton AE, Lee KL, Fisher JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med, 1999; 341: 1882-1890.
8. Kadish A, Dyer A, Daubert JP et al.; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med, 2004; 350: 2151-2158.
9. Bardy GH, Lee KL, Mark DB et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237.
10. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004; 350: 2140-2150.
11. Trappe HJ, Pfitzner P, Achtelik M et al. Age dependent efficacy of implantable cardioverter-defibrillator treatment: Observations in 450 patients over an 11 year period. Heart, 1997; 78: 364-370.
12. Hedges LV, Olkin I. Statistical methods for meta-analysis. Academic Press, Orlando 1985.
13. Healey JS, Hallstrom AP, Kuck KH et al. Role of the implantable defibrillator among elderly patients with a history of life- -threatening ventricular arrhythmias. Eur Heart J, 2007; 28: 1746-1749.
14. Bansch D, Antz M, Boczor S et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation, 2002; 105: 1453-1458.
15. Strickberger SA, Hummel JD, Bartlett TG et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia: AMIOVIRT. J Am Coll Cardiol, 2003; 41: 1707-1712.
16. Sanders GD, Inoue L, Samsa G et al. Use of Bayesian techniques in randomized clinical trials: A CMS case study. Evidence Report/Technology Assessment. Agency for Healthcare Research and Quality, Rockville, MD, 2009.
17. Peterson M. Do elderly benefit from defibrillator as primary prevention in coronary artery disease and left ventricular dysfunction? Pacing Clin Electrophysiol, 2003; 26: part II.
18. Huang DT, Sesselberg HW, McNitt S et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT-II Substudy. J Cardiovasc Electrophysiol, 2007; 18: 833-838.
19. Peto R. Why do we need systematic overviews of randomized trials? Stat Med, 1987; 6: 233-244.
20. Noseworthy PA, Lashevsky I, Dorian P et al. Feasibility of implantable cardioverter defibrillator use in elderly patients: A case series of octogenarians. Pacing Clin Electrophysiol, 2004; 27: 373-378.
21. Koplan BA, Epstein LM, Albert CM et al. Survival in octogenarians receiving implantable defibrillators. Am Heart J, 2006; 152: 714-719.
22. Duray G, Richter S, Manegold J et al. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol, 2005; 14: 169-173.
23. Grimm W, Stula A, Sharkova J et al. Outcomes of elderly recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol, 2007; 30 (suppl. 1): S134-S138.
24. Ermis C, Zhu AX, Vanheel L et al. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients > or = 75 years of age treated with implantable cardioverter defibrillators. Europace, 2007; 9: 270-274.
25. Chan PS, Nallamothu BK, Spertus JA et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter- defibrillators for primary prevention. Cardiovascular Quality and Outcomes. Circulation, 2009; 2: 16-24.
26. Alter P, Waldhans S, Plachta E et al. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol, 2005; 28: 926-932.
27. Buxton AE. Implantable cardioverter-defibrillators should be used routinely in the elderly. Am J Geriatr Cardiol, 2006; 15: 361-364 (quiz 365-366).
28. Quan KJ, Lee JH, Costantini O et al. Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years. Ann Thorac Surg, 1997; 64: 1713-1717.
29. Bailey SM, Wilkoff BL. Complications of pacemakers and defibrillators in the elderly. Am J Geriatr Cardiol, 2006;15: 102-107.
30. Reynolds MR, Cohen DJ, Kugelmass AD et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol, 2006; 47: 2493-2497.
31. Al-Khatib SM, Greiner MA, Peterson ED et al. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythmia Electrophysiol, 2008; 1: 240-249.
32. Schron EB, Exner DV, Yao Q et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation, 2002; 105: 589-594.
33. Irvine J, Dorian P, Baker B et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J, 2002; 144: 282-289.
34. Namerow PB, Firth BR, Heywood GM et al. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing Clin Electrophysiol, 1999; 28: 81-88.
35. Noyes K, Corona E, Zwanziger J et al. Health-related quality of life consequences of implantable cardioverter defibrillators: Results from MADIT II. Med Care, 2007; 45: 377-385.
36. Mark DB, Anstrom KJ, Sun JL et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med, 2008; 359: 999-1008.
37. Hamilton GA, Carroll DL. The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs, 2004; 13: 194-200.
38. Nichol G, Stiell IG, Hebert P et al. What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med, 1999; 6: 95-102.
39. Wenger NK. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol, 2006; 15: 352-356.
40. Daubert JP, Sesselberg HW, Huang DT. Implantable cardioverter- defibrillators for primary prevention: How do the data pertain to the aged? Am J Geriatr Cardiol, 2006; 15: 88-92.
41. Craney JM, Mandle CL, Munro BH et al. Implantable cardioverter defibrillators: Physical and psychosocial outcomes. Am J Crit Care, 1997; 6: 445-451.
42. Friedmann E, Thomas SA, Inguito P et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol, 2006; 17: 65-72.
43. Sossong A. Living with an implantable cardioverter defibrillator: Patient outcomes and the nurse's role. J Cardiovasc Nurs, 2007; 22: 99-104.
44. Thomas SA, Friedmann E, Kao CW et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care, 2006; 15: 389-398.
45. Grimm W. Outcomes of elderly heart failure recipients of ICD and CRT. Int J Cardiol, 2008; 125: 154-160.
46. Santangeli P, Di Biase L, Dello Russo A et al. Meta-analysis: Age and effectiveness of prophylactic implantable cardioverter- -defibrillators. Ann Intern Med, 2010; 153: 592-599.
47. Hammill SC, Stevenson LW, Kadish AH et al. Review of the registry's first year, data collected, and future plans. Heart Rhythm, 2007; 4: 1260-1263.
48. Greenberg H, Case RB, Moss AJ et al.; MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004; 43: 1459-1465.